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In response to the BP oil spill of 2010, 
Rotkin-Ellman et al. (2012) provide a 
thoughtful assessment of the Food and Drug 
Administration (FDA) risk criteria to protect 
vulnerable populations from exposure to poly-
cyclic aromatic hydrocarbons (PAHs) through 
seafood consumption (FDA 2010a). The 
FDA and the inter  agency partners involved in 
developing the seafood safety risk assessment 
for the BP oil spill shared the authors’ goal of 
establishing criteria that would be protective 
of all affected populations. Although Rotkin-
Ellman et al. present a well-intentioned case 
for determining PAH levels for at-risk popu-
lations, their interpretation of several factors 
involved in the derivation of levels of concern 
(LOC) differs substantially from those used in 
the BP oil spill risk assessment.
Human health risk assessments for 
environ  mental chemical contaminants are 
undertaken to develop exposure levels that 
are believed to be safe or associated with 
negligible risk. Uncertainty is inherent in 
any risk assessment process due to inter-
species, intra  species, and/or high-to-low dose 
extrapo  la  tions required for risk estimation. 
As a result, chemical risk assessments tend 
to be conservative with intentional bias on 
the side of safety. Unnecessarily conservative 
risk criteria, however, can have unintended 
nega  tive consequences for human health and 
society. The role of risk management is to 
balance what is known and unknown about 
a particular risk with the interests of public 
health protection and societal values. 
Development of the seafood safety risk 
assessment after the BP oil spill was a col-
laborative, highly iterative, and multi  agency 
process including departments of health from 
the five states bordering the Gulf of Mexico. 
The criteria agreed upon for PAHs with can-
cer end points provide conservative estimates 
of contamination levels and consumption 
rates that, if sustained for a period of 5 years, 
may result in a upper bound consumer life-
time cancer risk of 1 × 10–5. The agreed upon 
criteria for PAHs with noncancer end points 
are U.S. Environmental Protection Agency 
(EPA) reference doses for daily exposure of 
general and sensitive populations expected to 
have no significant risk of adverse effect dur-
ing a lifetime of exposure (U.S. EPA 2000).
A lifetime cancer risk level of 1 × 10–5 
implies a risk management decision to 
accept no more than a conservative estimate 
of one additional cancer case attributable to 
PAH-contaminated seafood in a population 
of 100,000 people. This risk level is within 
the acceptable range of values (i.e., 1 × 10–4 
to 1 × 10–6) observed by public health 
risk managers (U.S. EPA 1998a, 2000). 
Bias toward safety is also inherent in the 
derivation and selection of a benzo[a]pyrene 
cancer potency factor (7.3 mg/kg/day) based 
on the 95% upper confidence limit of the 
dose–response curve, rather than a maximum 
likeli  hood estimate. The actual cancer risk is 
believed to be somewhere below this upper 
confidence limit, and could be as low as zero 
(U.S. EPA 1994). The U.S. EPA value is 
more conservative than recent derivations of 
benzo[a]pyrene cancer potency factors, which 
incorporate adjustments for exposures during 
infancy (Office of Environmental Health 
Hazard Assessment 2010).
In regard to specific issues raised about 
selected underlying assumptions used in the 
risk assessment process, the FDA respectfully 
disagrees with the arguments of Rotkin-
Ellman et al. (2012). Various assumptions 
must be made in risk assessments in order 
to extrapolate data from animal or human 
studies using models to estimate population 
risks. Such models are designed to be overly 
protective to account for uncertainty and 
variability (e.g., upper 95% confidence 
bound on cancer risk values, and inter- 
and intra  species uncertainty factors on 
reference doses for non  carcinogens). Within 
this context, some numerical assumptions 
are based on average or mean values (e.g., 
average adult body weight and averaging 
time), and other assumptions are based on 
upper percentile values such as annualized 
food consumption rates. 
For purposes of risk assessment, aver-
age adult body weight may be viewed as an 
estimate of average lifetime body weight—
and averaging time as average lifespan—of 
people comprising a population. Because 
these factors are all condensed into a single 
number, there is often a range of values that 
it may be reasonable to use. Risk calcula-
tions include these factors in the derivation 
of contaminant thresholds for lifetime cancer 
risk and risk of adverse effect during a life-
time of exposure for non  cancer end points. 
The resulting threshold values reflect risk 
across the average lifespan of a population, 
including men, women (including pregnant 
women), and children. 
Seafood consumption data are collected 
for different purposes using a variety of survey 
instruments. It is important to note that 
surveys most often reflect short-term intake 
and do not necessarily address seasonality or 
other  wise directly capture annualized seafood 
consumption. The BP risk assessment (FDA 
2010a) used National Health and Nutrition 
Examination Survey (NHANES) 90th 
percentile consumption data for seafood 
eaters-only adjusted for consumption 
frequency (Centers for Disease Control 
and Prevention 2007). Meal portion and 
frequency (16.4 seafood meals/month) were 
converted to annualized daily equivalents. 
The selection of 5 years for projected 
exposure duration following the BP oil spill 
was considered appropriate and conservative 
in consideration of the nature of the spilled 
oil (i.e., light crude), physical conditions 
(e.g., 29.5°C water temperature), offshore 
location of the spill (50 miles), and metabolic 
capacities of seafood species potentially 
impacted. Exposure duration values selected 
in previous oil spill assessments range from 
2 years (e.g., New Carissa, Oregon, 1999) 
to 10 years (Exxon Valdez, Alaska, 1989). 
Corresponding fishery closures range from 
weeks to > 6 years for select species that 
were subjected to prolonged exposures (e.g., 
farmed salmon, burrowing lobster). In one 
of the areas most heavily contaminated 
after the Exxon Valdez spill (Windy Bay),   
benzo(a)pyrene equivalents decreased to 
non  detectable levels by 2.2 years after the 
contamination event (Bolger et al. 1996). 
Fisheries closures due to the BP oil spill 
range from 2 weeks for areas experiencing 
little to no impact to > 15 months for heavily 
impacted areas. The reopening of Gulf 
fisheries based on PAH chemical surveillance 
results confirmed that selection of a 5-year 
exposure duration was indeed appropriate and 
conservative (FDA 2010b; National Oceanic 
and Atmospheric Administration 2010). 
The classification of naphthalene as a 
non  cancer risk in the BP oil spill seafood 
safety risk assessment was based on cur-
rent information and concurrence from 
the U.S. EPA (FDA 2010a). The U.S EPA 
(1998b) classified naphthalene in “Group C, 
a possible human carcinogen. This is based on 
inadequate data of carcino  genicity in humans 
exposed to naphthalene via the oral or inha-
lation routes, and the limited evidence of 
carcinogenicity in animals via the inhalation 
route.” No oral slope factor or inhalation unit 
risk estimate were derived for naphthalene by 
the U.S. EPA because of the weakness of the 
evidence that naphthalene may be carcino-
genic to humans (U.S. EPA 1998b). More 
recent evaluations have maintained the non-
cancer risk classification of naphthalene, as 
evidenced by the 64th meeting of the Food 
and Agriculture Organization of the United 
Nations and the World Health Organization 
(FAO/WHO) Joint Expert Committee on 
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Food Additives (JECFA), which considered 
but did not include naphthalene among 
geno  toxic and carcino  genic PAHs evaluated 
(FAO/WHO 2006).
Although well intentioned, the LOC 
values suggested by Rotkin-Ellman et al. 
(2012) do not appear to take into account 
the natural background occurrence of PAHs 
in foods in many categories. Assessments 
from the body of scientific literature is 
perhaps best represented by the deliberations 
of JECFA (which included experts from the 
FDA), which found benzo(a)pyrene from 
dietary intake alone to range from 0.16 to   
3.3 µg/person/day (Benford et al. 2010; 
FAO/WHO 1991, 2006). The LOC values 
proposed by Rotkin-Ellman et al. (2012) 
would unnecessarily exclude many food 
groups from consumers, where nutritional 
benefits far outweighs negligible risk from 
PAHs. 
Public health authorities are responsible 
for protecting consumers from contami-
nated commercial and recreational seafood 
sources, and to that end advisories may be 
issued to protect consumers. The federal and 
state inter  agency risk assessment for seafood 
safety following the BP oil spill of 2010 was 
designed and agreed on by all participants to 
provide conservative criteria that protect the 
public. The alternative interpretation pro-
vided by Rotkin-Ellman et al. (2012) carries 
a risk of doing more harm than good. 
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We thank Dickey for the opportunity to 
discuss differing approaches to evaluating 
health risks from chemical contaminants in 
food, such as those in Gulf seafood after the 
BP oil spill disaster. As we demonstrate in 
our commentary, “Seafood Contamination 
after the BP Gulf Oil Spill and Risks to 
Vulnerable Populations: A Critique of the 
FDA Risk Assessment” (Rotkin-Ellman et al. 
2012), the choice of parameters and methods 
can significantly alter the conclusions of 
a risk assessment, thereby having major 
impacts on resulting policy decisions. In the 
example we analyzed, a risk assessment using 
parameters and methods specifically aimed 
at protecting vulnerable populations and 
incorporating the latest risk science differs 
from the Food and Drug Administration’s 
(FDA) approach (FDA 2010) by up to four 
orders of magnitude. 
Dickey characterizes chemical risk assess-
ments as inherently biased “on the side of 
safety” and is concerned that “unnecessarily 
conservative risk criteria” could harm human 
health and society as a whole. This view-
point, which is arguably rooted more in poli-
tics than in science, ignores the long history 
of chemical assessments where new data and 
approaches have repeatedly demonstrated sig-
nificantly greater risks than initially believed 
(Castorina and Woodruff 2003; Grandjean 
et al. 2010; Hernberg 2000). Furthermore, 
from a health-cost perspective, there is con-
siderable bene  fit to assuring that the popula-
tion is protected from harmful exposures to 
carcino  gens and other toxi  cants (Landrigan 
et al. 2002; Trasande et al. 2006). 
A National Research Council (NRC) 
committee reviewed the status of environ-
mental regulatory risk assessment and con-
cluded that the new science documenting 
inter  individual variability and the vulner-
ability of the developing fetus and child to 
chemical contaminants warrants specific 
changes to risk assessment practices (NRC 
2009). These changes were not reflected in 
the FDA assessment (FDA 2010). The jus-
tifications for the FDA’s risk criteria (FDA 
2010) that Dickey provides in his letter do 
not reflect the most current scientific under-
standing of the health risks from polycyclic 
aromatic hydrocarbons (PAHs)—or the risk 
assessment process—and therefore cannot be 
characterized as biased “on the side of safety.” 
The NRC, the U.S. Environmental 
Protection Agency (EPA), and the broader 
scientific community have recognized 
that children are not just small adults and 
that calculation of life-stage–specific doses 
are the most health protective method to 
ensure public health protection (American 
Academy of Pediatrics 2011; NRC 1993, 
2009; U.S. EPA 2005). This necessitates use 
of age-specific body weights and intake and 
specifically refutes the claim that an adult 
body weight and dose can represent risk 
across a lifespan.
The World Health Organization (WHO) 
and the U.S. EPA have recognized the 
extremely skewed nature of food consump-
tion curves and the resulting increased 
health risk to high-end consumers. These 
agencies recommended that risk assessments 
be based on either local surveys (if available) 
or the 95–97th percentile of national 
surveys (U.S. EPA 2000; WHO 2008). 
Previous studies that evaluated the utility of 
dietary data from the National Health and 
Nutrition Examination Survey (NHANES) 
against population-specific surveys have 
concluded that there is a risk of significantly 
under  estimating exposure among children if 
NHANES data are the sole source of dietary 
estimates (Riederer et al. 2010). Furthermore, 
alternative statistical techniques have been 
shown to allow better charac  teriza  tion of the 